ACOG committee opinion. Hormone replacement therapy in women treated for endometrial cancer. Number 234, May 2000 (replaces number 126, August 1993).
D000075202:Contraindications; D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000628:therapy*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced* / Q000453:epidemiology; D018579:Patient Selection; D011237:Predictive Value of Tests; D011379:Prognosis; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D020845:Selective Estrogen Receptor Modulators